000 | 01753 a2200493 4500 | ||
---|---|---|---|
005 | 20250518021908.0 | ||
264 | 0 | _c20191216 | |
008 | 201912s 0 0 eng d | ||
022 | _a1879-3185 | ||
024 | 7 |
_a10.1016/j.tox.2019.01.017 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLi, Xilin | |
245 | 0 | 0 |
_aThe effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice. _h[electronic resource] |
260 |
_bToxicology _c03 2019 |
||
300 |
_a1-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCaprylates _xtoxicity |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xetiology |
650 | 0 | 4 | _aConstitutive Androstane Receptor |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
650 | 0 | 4 | _aDiet, High-Fat |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDisease Progression |
650 | 0 | 4 |
_aEnvironmental Pollutants _xtoxicity |
650 | 0 | 4 |
_aFluorocarbons _xtoxicity |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNon-alcoholic Fatty Liver Disease _xetiology |
650 | 0 | 4 |
_aPPAR alpha _xgenetics |
650 | 0 | 4 |
_aPregnane X Receptor _xgenetics |
650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xgenetics |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aWang, Zemin | |
700 | 1 | _aKlaunig, James E | |
773 | 0 |
_tToxicology _gvol. 416 _gp. 1-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tox.2019.01.017 _zAvailable from publisher's website |
999 |
_c29321455 _d29321455 |